Biotechnology News and Research

RSS

New mRNA treatment appears to stop replication of flu and Covid-19 viruses

With a relatively minor genetic change, a new treatment developed by researchers at the Georgia Institute of Technology and Emory University appears to stop replication of both flu viruses and the virus that causes Covid-19.

4 Mar 2021

Compound isolated from Moroccan fungus shows promise to fight triple negative breast cancer

A compound isolated from a fungus growing on the roots of a flowering plant in Morocco shows promise as a powerful opponent of aggressive triple negative breast cancer, scientists say.

4 Mar 2021

Cigarette smoke toxicity impacts protective biofilm in the lungs, study finds

Ben-Gurion University of the Negev Researchers (BGU) have found for the first time that cigarette smoke toxicity impacts the protective biofilm in the lungs, particularly concerning when paired with COVID-19 respiratory issues.

3 Mar 2021

Beckman Coulter Life Sciences Debuts Biomek NGeniuS Workstation at AGBT

Celebrating more than 85 years of innovation, Beckman Coulter Life Sciences announces its newest automated liquid handler, the Biomek NGeniuS workstation, at the virtual Advances in Genome Biology and Technology (AGBT) General Meeting.

From Beckman Coulter Life Sciences - Flow Cytometry 3 Mar 2021

Study reveals how cells build 'mini-muscles' underneath their nucleus

Research groups at the University of Helsinki uncovered how motor protein myosin, which is responsible for contraction of skeletal muscles, functions also in non-muscle cells to build contractile structures at the inner face of the cell membrane.

2 Mar 2021

Scientists reprogram a common bacterium to make designer sugar-based drug

Envisioning an animal-free drug supply, scientists have - for the first time - reprogrammed a common bacterium to make a designer polysaccharide molecule used in pharmaceuticals and nutraceuticals.

2 Mar 2021

Evonik partners with BioNTech to manufacture lipids for COVID-19 vaccine

Caused by SARS-CoV-2, the coronavirus disease 2019 (COVID-19) pandemic continues to spread across the globe.

From Evonik 2 Mar 2021

Biological activity-based modeling offers a new approach for drug discovery

Assessing a drug compound by its activity, not simply its structure, is a new approach that could speed the search for COVID-19 therapies and reveal more potential therapies for other diseases.

2 Mar 2021

Emerging protein-based immunotherapies could lead to highly effective cancer treatments

In a new commentary for the journal Science, an associate vice president for research at The University of Texas at Arlington argues that emerging protein-based immunotherapies could lead to highly effective "off-the-shelf" cancer treatments for more patients.

1 Mar 2021

Why Astrazeneca and J&J’s vaccines, in use the world over, are still on hold in America

The World Health Organization greenlighted emergency use of AstraZeneca and Oxford's covid-19 vaccine this month, following in the steps of the United Kingdom, the European Union and others, who are already injecting it as quickly as possible into the masses.

26 Feb 2021

New, more reliable testing program rolled-out to hospital staff to curb Covid transmission rates

Frontline staff at Norfolk and Norwich University Hospitals are among the first in the country to benefit from the rollout of more accurate saliva tests in a bid to curb Covid transmission rates.

25 Feb 2021

Insilico Medicine discovers novel preclinical candidate to address idiopathic pulmonary fibrosis

Insilico Medicine has demonstrated a breakthrough in Artificial Intelligence ("AI") and drug discovery -- linking together generative chemistry and biology for the first time -- to discover a novel preclinical candidate addressing idiopathic pulmonary fibrosis ("IPF") and be validated with multiple human cell and animal model experiments.

25 Feb 2021

HSE researchers discover genetic predisposition to COVID-19 severity

HSE University researchers have become the first in the world to discover genetic predisposition to severe COVID-19. The results of the study were published in the journal Frontiers in Immunology.

23 Feb 2021

Study provides better understanding of metabolic routes involved in regulating satiety

Results of the European study SATIN (SATiety INnovation) reveal a relation between certain metabolites in the blood and the satiety perceived after consuming food.

22 Feb 2021

A promising strategy to improve functional capacity of damaged muscle

Muscle is the largest organ that accounts for 40% of body mass and plays an essential role in maintaining our lives.

21 Feb 2021

An optimized process to isolate and purify magnetic nanoparticles

Magnetic nanoparticles biosynthesized by bacteria might soon play an important role in biomedicine and biotechnology. Researchers of the University of Bayreuth have now developed and optimized a process for the isolation and purification of these particles from bacterial cells.

19 Feb 2021

Researchers develop new tool for tackling disseminated intravascular coagulation

Researchers have developed a new tool for addressing disseminated intravascular coagulation (DIC) - a blood disorder that proves fatal in many patients.

17 Feb 2021

Researchers develop non-cereal crop to enhance yields and consumer health

Delivering the benefits of agricultural biotechnology to smallholder farmers requires that resources be directed toward staple food crops.

17 Feb 2021

Composition of protein solution plays a decisive role in cataract formation

Cataracts are the most common eye ailment in humans. However, the exact processes leading to this condition are not fully understood.

17 Feb 2021

Study: Targeted therapy prolongs survival in patients with advanced bladder cancer

In a new study led by researchers at Yale Cancer Center, the drug enfortumab vedotin (EV) significantly prolonged survival as compared with standard chemotherapy in patients with locally advanced or metastatic urothelial carcinoma or bladder cancer, who had previously received platinum-based treatment and a PD-1–PD-L1 inhibitor.

15 Feb 2021

Biotechnology News and Research

New mRNA treatment appears to stop replication of flu and Covid-19 viruses

Compound isolated from Moroccan fungus shows promise to fight triple negative breast cancer

Cigarette smoke toxicity impacts protective biofilm in the lungs, study finds

Beckman Coulter Life Sciences Debuts Biomek NGeniuS Workstation at AGBT

Study reveals how cells build 'mini-muscles' underneath their nucleus

Scientists reprogram a common bacterium to make designer sugar-based drug

Evonik partners with BioNTech to manufacture lipids for COVID-19 vaccine

Biological activity-based modeling offers a new approach for drug discovery

Emerging protein-based immunotherapies could lead to highly effective cancer treatments

Why Astrazeneca and J&J’s vaccines, in use the world over, are still on hold in America

New, more reliable testing program rolled-out to hospital staff to curb Covid transmission rates

Insilico Medicine discovers novel preclinical candidate to address idiopathic pulmonary fibrosis

HSE researchers discover genetic predisposition to COVID-19 severity

Study provides better understanding of metabolic routes involved in regulating satiety

A promising strategy to improve functional capacity of damaged muscle

An optimized process to isolate and purify magnetic nanoparticles

Researchers develop new tool for tackling disseminated intravascular coagulation

Researchers develop non-cereal crop to enhance yields and consumer health

Composition of protein solution plays a decisive role in cataract formation

Study: Targeted therapy prolongs survival in patients with advanced bladder cancer

Event guide: 3rd IMPACCT Real World Evidence Summit Europe eBook

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News